P. Lakatos

P. Lakatos, M. Dank, B. Balla, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Comprehensive examination of somatic oncogene mutation in normal and pathologic thyroid tissues

P. Lakatos, B. Balla, Z. Nagy, 2011 .

DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.

P. Rutgeerts, S. Vermeire, T. Molnár, 2006 .

DLG5 R30Q is not associated with IBD in Hungarian IBD patients but predicts clinical response to steroids in Crohn's disease.

P. Rutgeerts, S. Vermeire, T. Molnár, 2006, Inflammatory bowel diseases.

New Serological Markers for Inflammatory Bowel Disease Are Associated With Earlier Age at Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

T. Molnár, M. Papp, Z. Tulassay, 2008, The American Journal of Gastroenterology.

Perianal disease, small bowel disease, smoking, prior steroid or early azathioprine/biological therapy are predictors of disease behavior change in patients with Crohn's disease.

P. Lakatos, J. Papp, J. Banai, 2009, World journal of gastroenterology.

Acute phase proteins in the diagnosis and prediction of cirrhosis associated bacterial infections

M. Papp, P. Lakatos, I. Tornai, 2012, Liver international : official journal of the International Association for the Study of the Liver.

Ribavirin in the treatment of hepatitis C.

P. Lakatos, M. Abonyi, 2005, Anticancer research.

Systematic review and meta-analysis of colon cleansing preparations in patients with inflammatory bowel disease

A. Barkun, O. Kherad, P. Lakatos, 2017, World journal of gastroenterology.

Effects of gallium nitrate on calcium transients in UMR-106 rat osteoblastic osteosarcoma cells.

P. Lakatos, P. Stern, A. Tatrai, 1992, Bone.

Effects of endothelin‐1 on signal transduction in UMR‐106 osteoblastic cells

P. Lakatos, P. Stern, A. Tatrai, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update.

M. Ferrante, L. Peyrin-Biroulet, G. Fiorino, 2017, Journal of Crohn's & colitis.

Common mutations of ATP7B in Wilson disease patients from Hungary.

T. Glant, P. Lakatos, C. Polli, 2002, American journal of medical genetics.

Mechanisms of action of antiresorptive therapies of postmenopausal osteoporosis.

P. Lakatos, J. Feyen, G. Boivin, 2003, Endocrine regulations.

The red deer Cervus elaphus genome CerEla1.0: sequencing, annotating, genes, and chromosomes

E. Barta, P. Horn, P. Lakatos, 2018, Molecular Genetics and Genomics.

[Prevalence of osteoporosis in patients with severe peripheral artery disease].

P. Lakatos, Z. Szeberin, Z. Oláh, 2013, Orvosi hetilap.

Epidemiology, mortality and prevalence of colorectal cancer in ulcerative colitis patients between 2010-2016 in Hungary – a population-based study

K. Farkas, T. Molnár, P. Lakatos, 2020, PloS one.

[Literature review and presentation of our own research results regarding the effects on bone of tyrosine kinase inhibitors imatinib and nilotinib used in the treatment of oncohematological diseases].

P. Horváth, P. Lakatos, B. Balla, 2016, Orvosi hetilap.

Mucosal Healing with Anti-TNF Antibodies

G. Rogler, A. Schoepfer, S. Vavricka, 2012, Digestion.

Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients

Z. Tulassay, P. Lakatos, P. Miheller, 2009, Inflammatory bowel diseases.

Hospitalisations and surgery in Crohn's disease

S. Ng, C. Bernstein, B. Moum, 2012, Gut.

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary

D. Hans, P. Lakatos, B. Obermayer-Pietsch, 2011, Archives of osteoporosis.

Dietary Calcium Intake and Calcium Supplementation in Hungarian Patients with Osteoporosis

P. Lakatos, G. Speer, Pál Szamosújvári, 2013, International journal of endocrinology.

LCT 13910 C/T polymorphism, serum calcium, and bone mineral density in postmenopausal women

P. Lakatos, Á. Lazáry, B. Balla, 2009, Osteoporosis International.

[Impact of CYP3A7*1C polymorphism on bone mineral content in postmenopausal women].

P. Lakatos, Á. Lazáry, B. Balla, 2007, Orvosi hetilap.

CYP3A7*1C Polymorphism, Serum Dehydroepiandrosterone Sulfate Level, and Bone Mineral Density in Postmenopausal Women

P. Lakatos, G. Borgulya, Á. Lazáry, 2007, Calcified Tissue International.

Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study

R. Recker, J. Stakkestad, P. Miller, 2012, Osteoporosis International.

Environmental Factors Affecting Inflammatory Bowel Disease: Have We Made Progress?

P. Lakatos, 2009, Digestive Diseases.

Fast and Robust Next-Generation Sequencing Technique Using Ion Torrent Personal Genome Machine for the Screening of Neurofibromatosis Type 1 (NF1) Gene

P. Horváth, P. Lakatos, M. Dank, 2014, Journal of Molecular Neuroscience.

Strong effect of SNP rs4988300 of the LRP5 gene on bone phenotype of Caucasian postmenopausal women

P. Horváth, P. Lakatos, B. Balla, 2014, Journal of Bone and Mineral Metabolism.

Marked increase in CYP24A1 gene expression in human papillary thyroid cancer.

P. Lakatos, B. Balla, J. Kósa, 2011, Thyroid : official journal of the American Thyroid Association.

The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis

P. Hershberger, E. Kallay, P. Lakatos, 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Autonomic and sensory nerve dysfunction in primary biliary cirrhosis.

P. Lakatos, P. Kempler, F. Szalay, 2004, World journal of gastroenterology.

The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease.

H. Tilg, T. Karlsen, K. Boberg, 2016, Journal of Crohn's & colitis.

Low incidence of venous thromboembolism in inflammatory bowel diseases: prevalence and predictors from a population-based inception cohort

P. Lakatos, K. Gecse, L. Lakatos, 2015, Scandinavian journal of gastroenterology.

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, World journal of gastroenterology.

Manipulating bone disease in inflammatory bowel disease patients

P. Lakatos, P. Miheller, William Gesztes, 2013, Annals of gastroenterology.

The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON‐Pivotal Fracture Trial (PFT)

S. Cummings, J. Cauley, I. Reid, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[Pharmacologic treatment of osteoporosis--2011].

P. Lakatos, 2011, Orvosi hetilap.

Management of Acute Severe Colitis in the Era of Biologicals and Small Molecules

P. Lakatos, T. Bessissow, C. Verdon, 2019, Journal of clinical medicine.

Have Biologics Changed the Natural History of Crohn's Disease?

P. Lakatos, M. Mandel, P. Miheller, 2014, Digestive Diseases.

Development of an index to define overall disease severity in IBD

S. Ng, C. O'Morain, M. Silverberg, 2016, Gut.

Can We Say No to the 'Nocebo Effect' in Inflammatory Bowel Diseases?

P. Lakatos, L. Gonczi, 2019, Journal of Crohn's & colitis.

CYP24A1 inhibition facilitates the anti-tumor effect of vitamin D3 on colorectal cancer cells.

P. Horváth, P. Mátyus, P. Lakatos, 2013, World journal of gastroenterology.

CYP 24 A 1 inhibition facilitates the anti-tumor effect of vitamin D 3 on colorectal cancer cells

P. Horváth, P. Mátyus, P. Lakatos, 2013 .

P120 The Atp-Binding Cassette Transporter ABCG2 (BCRP) and ABCB1 (MDR1) Variants are not Associated With Disease Susceptibility, Disease Phenotype, Response to Medical Therapy or Need For Surgery in Hungarian Patients with Inflammatory Bowel Diseases

T. Molnár, M. Papp, Z. Tulassay, 2007 .

Endoscopic surveillance strategies for dysplasia in ulcerative colitis

P. Lakatos, A. Aruljothy, T. Bessissow, 2019, Frontline Gastroenterology.

Safety and Efficacy of Weekly 30,000 IU Vitamin D Supplementation as aSlower Loading Dose Administration Compared to a Daily MaintenanceSchedule in Deficient Patients: A Randomized, Controlled Clinical Trial

P. Lakatos, Béla E Tóth, I. Takács, 2017 .

Safety and Efficacy of Weekly 30,000 IU Vitamin D Supplementation as a Slower Loading Dose Administration Compared to a Daily Maintenance Schedule in Deficient Patients: A Randomized, Controlled Clinical Trial

P. Lakatos, Béla E Tóth, I. Takács, 2017 .

Treatment of Extraintestinal Manifestations in Inflammatory Bowel Disease

A. Schoepfer, S. Vavricka, L. Peyrin-Biroulet, 2012, Digestion.

Management of Patients With Crohn’s Disease and Ulcerative Colitis During the Coronavirus Disease-2019 Pandemic: Results of an International Meeting

S. Ng, C. Lees, C. O'Morain, 2020, Gastroenterology.

Selection of Quality Indicators in IBD: Integrating Physician and Patient Perspectives.

A. Bitton, M. Sewitch, P. Lakatos, 2018, Inflammatory bowel diseases.

The management of iron deficiency in inflammatory bowel disease – an online tool developed by the RAND/UCLA appropriateness method

C. Lees, M. Toruner, O. Nielsen, 2013, Alimentary pharmacology & therapeutics.

Genetic Alterations in Hungarian Patients with Papillary Thyroid Cancer

P. Horváth, B. Iványi, P. Lakatos, 2015, Pathology & Oncology Research.

Correction of vitamin D deficiency improves seizure control in epilepsy: A pilot study

A. Szűcs, Z. Clemens, A. Kamondi, 2012, Epilepsy & Behavior.

Oestrogen and vitamin D receptor (VDR) genotypes and the expression of ErbB-2 and EGF receptor in human rectal cancers.

P. Lakatos, G. Winkler, K. Cseh, 2001, European journal of cancer.

Costs and Resource Utilization for Diagnosis and Treatment During the Initial Year in a European Inflammatory Bowel Disease Inception Cohort: An ECCO-EpiCom Study

C. O'Morain, V. Andersen, L. Kupčinskas, 2015, Inflammatory bowel diseases.

Lack of association between calcium-sensing receptor gene "A986S" polymorphism and bone mineral density in Hungarian postmenopausal women.

P. Lakatos, Á. Tabák, É. Bajnok, 2002, Bone.

Association between collagen type I alpha1 (COL1A1) gene Sp1-, calcium-sensing receptor (CaSR) gene A986S-, interleukin-1 receptor antagonist (IL-1LN) gene VNTR Polymorphisms and osteoporosis; Their impact in prediction of osteoporotic bone fracture.

A. Lakatos, P. Lakatos, Á. Tabák, 2004 .

Thyroid Hormones: Beneficial or Deleterious for Bone?

P. Lakatos, 2003, Calcified Tissue International.

Bone Homeostasis in Intestinal Disorders

M. Tóth, P. Lakatos, P. Miheller, 2010 .

Does dermatitis herpetiformis result in bone loss as coeliac disease does? A cross sectional study.

T. Zágoni, Z. Tulassay, P. Lakatos, 2013, Revista espanola de enfermedades digestivas : organo oficial de la Sociedad Espanola de Patologia Digestiva.

Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.

P. Lakatos, Á. Lazáry, B. Balla, 2010, European journal of endocrinology.

Monthly oral ibandronate is effective and well tolerated after 3 years: the MOBILE long-term extension

J. Reginster, J. Stakkestad, P. Lakatos, 2008, Clinical Rheumatology.

Serum bone GLA protein in streak gonad syndrome

J. László, P. Lakatos, P. Vargha, 1991, Calcified Tissue International.

L. Peyrin-Biroulet, P. Lakatos, S. Danese, 2019, Current medicinal chemistry.

Effect of gypsum on proliferation and differentiation of MC3T3-E1 mouse osteoblastic cells.

P. Lakatos, Á. Lazáry, B. Balla, 2007, Biomaterials.

New serological markers in pediatric patients with inflammatory bowel disease.

G. Veres, M. Papp, P. Lakatos, 2014, World journal of gastroenterology.

Low mannose-binding lectin (MBL) is associated with paediatric inflammatory bowel diseases and ileal involvement in patients with Crohn disease.

G. Veres, M. Papp, P. Lakatos, 2013, Journal of Crohn's & colitis.

Pancreatic Autoantibodies and Autoantibodies Against Goblet Cells in Pediatric Patients With Inflammatory Bowel Disease

G. Veres, M. Papp, P. Lakatos, 2012, Journal of pediatric gastroenterology and nutrition.

Intestinal alkaline phosphatase in the colonic mucosa of children with inflammatory bowel disease.

G. Veres, M. Papp, P. Lakatos, 2012, World journal of gastroenterology.

Serologic Antiglycan Antibodies in Inflammatory Bowel Disease

M. Papp, P. Lakatos, F. Rieder, 2011, The American Journal of Gastroenterology.

Mannose-binding lectin level and deficiency is not associated with inflammatory bowel diseases, disease phenotype, serology profile, and NOD2/CARD15 genotype in a large Hungarian cohort.

G. Veres, K. Farkas, F. Nagy, 2010, Human immunology.

Anti-microbial antibodies in celiac disease: trick or treat?

G. Veres, I. Korponay-Szabó, A. Tordai, 2009, World journal of gastroenterology.

A budget impact model for biosimilar infliximab in Crohn’s disease in Bulgaria, the Czech Republic, Hungary, Poland, Romania, and Slovakia

P. Lakatos, M. Péntek, P. Baji, 2015, Expert review of pharmacoeconomics & outcomes research.

The protective role of bone morphogenetic protein-8 in the glucocorticoid-induced apoptosis on bone cells.

P. Lakatos, B. Balla, J. Kósa, 2011, Bone.

Endothelin receptors, second messengers, and actions in bone.

P. Lakatos, P. Stern, G. Tarján, 1995, The Journal of nutrition.

The natural history of Crohn’s disease in children: a review of population-based studies

V. Annese, L. Peyrin-Biroulet, P. Lakatos, 2017, European journal of gastroenterology & hepatology.

Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial

Jacques P. Brown, H. Genant, A. Grauer, 2017, The Lancet.

Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond

A. Tordai, L. Truedsson, M. López-Trascasa, 2004, Journal of Allergy and Clinical Immunology.

East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort

N. Pedersen, E. Björnsson, V. Andersen, 2013, Gut.

Immune dysfunction in cirrhosis.

M. Papp, P. Lakatos, N. Sipeki, 2014, World journal of gastroenterology.

Haptoglobin Polymorphisms Are Associated with Crohn’s Disease, Disease Behavior, and Extraintestinal Manifestations in Hungarian Patients

T. Molnár, M. Papp, P. Lakatos, 2007, Digestive Diseases and Sciences.

Increased nociceptin/orphanin FQ plasma levels in hepatocellular carcinoma.

P. Lakatos, F. Szalay, A. Folhoffer, 2004, World journal of gastroenterology.

CHAPTER 20 – Other Pharmacologic Agents Influencing Bone Loss

P. Lakatos, P. Stern, 1999 .

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

P. Lakatos, L. Lakatos, Z. Erdélyi, 2004, World journal of gastroenterology.

Serum interleukin-6 and bone metabolism in patients with thyroid function disorders.

P. Lakatos, P. Stern, G. Tarján, 1997, The Journal of clinical endocrinology and metabolism.

Elevated serum tumor necrosis factor-alpha and endothelin 1 levels correlate with increased C-peptide concentration in android type obesity.

P. Lakatos, G. Winkler, K. Cseh, 1998, Diabetes care.

[Prediction of the disease course in inflammatory bowel diseases].

P. Lakatos, L. Kiss, 2010, Orvosi hetilap.

Is the disease course predictable in inflammatory bowel diseases?

P. Lakatos, L. Kiss, 2010, World journal of gastroenterology.

The IL-10R1 S138G loss-of-function allele and ulcerative colitis

S. Murray, P. Rutgeerts, S. Vermeire, 2009, Genes and Immunity.

Common NOD2/CARD15 variants are not associated with susceptibility or the clinicopathologic characteristics of sporadic colorectal cancer in Hungarian patients

G. Veres, E. Hitre, P. Lakatos, 2007, BMC Cancer.

Toll-like receptor 4 and NOD2/CARD15 mutations in Hungarian patients with Crohn's disease: phenotype-genotype correlations.

T. Molnár, Z. Tulassay, W. Reinisch, 2005, World journal of gastroenterology.

Gene polymorphisms in primary biliary cirrhosis: association with the disease and hepatic osteopathy

P. Lakatos, P. Ferenci, F. Szalay, 2007 .

Vitamin D receptor, oestrogen receptor-alpha gene and interleukin-1 receptor antagonist gene polymorphisms in Hungarian patients with primary biliary cirrhosis

P. Lakatos, F. Szalay, É. Bajnok, 2002, European journal of gastroenterology & hepatology.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

N. Pedersen, C. O'Morain, E. Bjornsson, 2014, Journal of Crohn's & colitis.

Importance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases

P. Lakatos, Á. Lazáry, B. Balla, 2007 .

Abnormal glucose tolerance is associated with diminished postload change in leptin levels in women

P. Lakatos, Á. Tabák, G. Tamás, 2009, Diabetes/metabolism research and reviews.

Defining Endpoints and Biomarkers in Inflammatory Bowel Disease: Moving the Needle Through Clinical Trial Design.

D. McGovern, S. Hanauer, B. Sands, 2020, Gastroenterology.

Clinical aspects of mucosal healing in inflammatory bowel diseases: what is it and what is the real value for the everyday practice?

P. Lakatos, M. Mandel, P. Miheller, 2013, Expert review of clinical immunology.

Physician perspectives on unresolved issues in the use of conventional therapy in Crohn's disease: results from an international survey and discussion programme.

S. Travis, M. Ferrante, G. Van Assche, 2012, Journal of Crohn's & colitis.

Harmonization of quality of care in an IBD center impacts disease outcomes: Importance of structure, process indicators and rapid access clinic.

A. Bitton, E. Seidman, P. Lakatos, 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies.

A. Bitton, P. Lakatos, W. Afif, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Construction and validation of a web-based epidemiological database for inflammatory bowel diseases in Europe An EpiCom study.

V. Andersen, A. Hart, J. Dahlerup, 2011, Journal of Crohn's & colitis.

Incidence, Paris Classification, and Follow-up in a Nationwide Incident Cohort of Pediatric Patients With Inflammatory Bowel Disease

G. Veres, M. Papp, P. Lakatos, 2013, Journal of pediatric gastroenterology and nutrition.

Comforting Data on the Incidence of Rectal Cancer After Subtotal Colectomy in IBD: The Risk Is Low, Yet Surveillance Matters!

P. Lakatos, P. Wetwittayakhlang, 2021, Journal of Crohn's & colitis.

Selection criteria for preoperative endoscopic retrograde cholangiopancreatography before laparoscopic cholecystectomy and endoscopic treatment of bile duct stones: results of a retrospective, single center study between 1996-2002.

P. Lakatos, L. Lakatos, Gábor Mester, 2004, World journal of gastroenterology.

Care of the Patient with IBD Requiring Hospitalization During the COVID-19 Pandemic

D. Rubin, R. Gearry, P. Lakatos, 2020, Journal of Crohn's & Colitis.

Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study

V. Andersen, L. Kupčinskas, S. Sebastian, 2019, Journal of gastroenterology and hepatology.

Clinical presentation of Crohn's disease. association between familial disease, smoking, disease phenotype, extraintestinal manifestations and need for surgery.

T. Molnár, Z. Tulassay, P. Lakatos, 2005, Hepato-gastroenterology.

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations.

C. Buskens, G. Rogler, S. Vavricka, 2017, Journal of Crohn's & colitis.

The use of 5-aminosalicylate for patients with Crohn’s disease in a prospective European inception cohort with 5 years follow-up – an Epi-IBD study

V. Andersen, J. Dahlerup, S. Sebastian, 2020, United European gastroenterology journal.

No Change in Surgical and Hospitalization Trends Despite Higher Exposure to Anti-Tumor Necrosis Factor in Inflammatory Bowel Disease in the Québec Provincial Database From 1996 to 2015.

A. Bitton, E. Seidman, P. Lakatos, 2020, Inflammatory bowel diseases.

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study.

V. Andersen, J. Dahlerup, M. Friger, 2020, The lancet. Gastroenterology & hepatology.

Trends in hospitalisation rates for inflammatory bowel disease in western versus newly industrialised countries: a population-based study of countries in the Organisation for Economic Co-operation and Development.

S. Ng, F. Underwood, G. Kaplan, 2019, The lancet. Gastroenterology & hepatology.

Therapeutic preferences and outcomes in newly diagnosed patients with Crohn’s diseases in the biological era in Hungary: a nationwide study based on the National Health Insurance Fund database

P. Lakatos, Z. Végh, P. Golovics, 2018, BMC Gastroenterology.

Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study

C. O'Morain, V. Andersen, L. Kupčinskas, 2017, Journal of Crohn's & colitis.

The epidemiology of inflammatory bowel diseases from West to East

P. Lakatos, Z. Végh, Z. Kurti, 2017 .

Nationwide prevalence and drug treatment practices of inflammatory bowel diseases in Hungary: A population-based study based on the National Health Insurance Fund database.

P. Lakatos, K. Gecse, Z. Végh, 2016, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Frequency of anaemia and anaemia subtypes in east-west European inception cohort : an ECCO-EpiCom cohort study

V. Andersen, L. Kupčinskas, J. Dahlerup, 2016 .

Risk Matrix for Prediction of Disease Progression in a Referral Cohort of Patients with Crohn's Disease.

M. Papp, P. Lakatos, Z. Shums, 2015, Journal of Crohn's & colitis.

Treatment Steps, Surgery, and Hospitalization Rates During the First Year of Follow-up in Patients with Inflammatory Bowel Diseases from the 2011 ECCO-Epicom Inception Cohort.

P. Lakatos, P. Munkholm, E. Langholz, 2015, Journal of Crohn's & colitis.

Novel Drug Therapies for the Treatment of Crohn's Disease

P. Lakatos, P. Miheller, Z. Végh, 2015 .

Biological therapy in inflammatory bowel diseases: access in Central and Eastern Europe.

L. Kupčinskas, A. Śliwczyński, P. Lakatos, 2015, World journal of gastroenterology.

P. Lakatos, J. Burisch, T. Jess, 2014, Journal of Crohn's & colitis.

Incidence and initial disease course of inflammatory bowel diseases in 2011 in Europe and Australia: results of the 2011 ECCO-EpiCom inception cohort.

L. Kupčinskas, P. Lakatos, P. Munkholm, 2014, Journal of Crohn's & colitis.

Health care and patients' education in a European inflammatory bowel disease inception cohort: an ECCO-EpiCom study.

C. O'Morain, E. Björnsson, V. Andersen, 2014, Journal of Crohn's & colitis.

Inflammatory bowel disease course in Crohn's disease: is the natural history changing?

P. Lakatos, M. Mandel, P. Golovics, 2014, World journal of gastroenterology.

Unmet Medical Needs in Ulcerative Colitis: An Expert Group Consensus

J. Gisbert, S. Vermeire, A. Hart, 2019, Digestive Diseases.

Epilepsy and Vitamin D

Z. Clemens, A. Holló, P. Lakatos, 2014, The International journal of neuroscience.

The role of serum total and free 25-hydroxyvitamin D and PTH values in defining vitamin D status at the end of winter: a representative survey

P. Lakatos, Á. Tabák, B. Balla, 2015, Journal of Bone and Mineral Metabolism.

[Hungarian consensus regarding the role of vitamin D in the prevention and treatment of diseases].

B. Merkely, T. Kovács, Nóra Bittner, 2012, Orvosi hetilap.

Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Vitamin D level in Hungarian patients with inflammatory bowel diseases].

Z. Tulassay, M. Tóth, P. Lakatos, 2013, Orvosi hetilap.

Hormonal and biochemical parameters correlated with bone densitometric markers in prepubertal Hungarian children.

G. Kovacs, P. Lakatos, B. Kálmán, 2013, Bone.

Bone Mineral Density is Associated with Site-Specific Atherosclerosis in Patients with Severe Peripheral Artery Disease

L. Entz, P. Sótonyi, P. Lakatos, 2013, Calcified Tissue International.

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

E. Hitre, P. Lakatos, Á. Lazáry, 2008, BMC Cancer.

Seroreactivity to microbial components in Crohn's disease is associated with ileal involvement, noninflammatory disease behavior and NOD2/CARD15 genotype, but not with risk for surgery in a Hungarian cohort of IBD patients

G. Veres, T. Molnár, M. Papp, 2007, Inflammatory bowel diseases.

Relationship between serum calcium and CA 19-9 levels in colorectal cancer.

P. Lakatos, Á. Tabák, J. Papp, 2004, World journal of gastroenterology.

Extraintestinal Manifestations of Inflammatory Bowel Disease

G. Rogler, A. Schoepfer, S. Vavricka, 2015, Inflammatory bowel diseases.

Vitamin D receptor, oestrogen receptor-α and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone

P. Lakatos, P. Gergely, Á. Tabák, 2004 .

Prevalence, predictors, and clinical consequences of medical adherence in IBD: how to improve it?

P. Lakatos, 2009, World journal of gastroenterology.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Medical Treatment.

J. Gisbert, S. Bonovas, E. Savarino, 2021, Journal of Crohn's & colitis.

Development of multiple myeloma in a patient with chronic hepatitis C: A case report and review of the literature.

P. Lakatos, S. Fischer, M. Abonyi, 2006, World journal of gastroenterology.

Infliximab biosimilar CT-P13 therapy is effective and safe in maintaining remission in Crohn’s disease and ulcerative colitis – experiences from a single center

K. Farkas, F. Nagy, T. Molnár, 2017, Expert opinion on biological therapy.

Association of adherence to therapy and complementary and alternative medicine use with demographic factors and disease phenotype in patients with inflammatory bowel disease.

F. Nagy, M. Papp, P. Lakatos, 2010, Journal of Crohn's & colitis.

[Treatment adherence and use of complementary and alternative medicine in patients with inflammatory bowel disease].

T. Molnár, M. Papp, P. Lakatos, 2010, Orvosi hetilap.

Levels of anti-double-strained DNA but not antinuclear antibodies are associated with treatment efficacy and adverse outcomes in Crohn's disease patients treated with anti-TNFα.

K. Farkas, T. Molnár, M. Papp, 2013, Journal of gastrointestinal and liver diseases : JGLD.

Vitamin D receptor gene polymorphism in rheumatoid arthritis and associated osteoporosis

P. Lakatos, S. Sipka, P. Rass, 2006, Rheumatology International.

P. Lakatos, K. Gecse, 2016, Drugs.

Prevention of corticosteroid-induced osteoporosis by alfacalcidol

P. Lakatos, I. Takács, G. Speer, 2000, Zeitschrift für Rheumatologie.

Osteoprotegerin Levels in Women With Prior Gestational Diabetes Mellitus Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

P. Lakatos, Á. Tabák, G. Tamás, 2009, Diabetes Care.

Benefits of implementing a rapid access clinic in a high-volume inflammatory bowel disease center: Access, resource utilization and outcomes

A. Bitton, E. Seidman, P. Lakatos, 2020, World journal of gastroenterology.

Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.

L. Mosekilde, J. Bilezikian, M. Brandi, 2013, The lancet. Diabetes & endocrinology.

High serum osteoprotegerin and low RANKL in primary biliary cirrhosis.

P. Lakatos, I. Tornai, F. Szalay, 2003, Journal of hepatology.

The rs4844880 polymorphism in the promoter region of the HSD11B1 gene associates with bone mineral density in healthy and postmenopausal osteoporotic women

K. Rácz, M. Tóth, P. Lakatos, 2012, Steroids.

Eldelumab [Anti-IP-10] Induction Therapy for Ulcerative Colitis: A Randomised, Placebo-Controlled, Phase 2b Study.

B. Sands, Li-an Xu, W. Sandborn, 2016, Journal of Crohn's & colitis.

Tuberculin Skin Test and Quantiferon in BCG Vaccinated, Immunosuppressed Patients with Moderate-to-Severe Inflammatory Bowel Disease.

K. Farkas, T. Molnár, P. Lakatos, 2015, Journal of gastrointestinal and liver diseases : JGLD.

Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection.

J. Maul, A. Schoepfer, G. Moran, 2009, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Skeletal Effects of Thyroid Hormones

P. Lakatos, P. Stern, I. Takács, 2018, Clinical Reviews in Bone and Mineral Metabolism.

Patient-Reported Outcome and Clinical Scores Are Equally Accurate in Predicting Mucosal Healing in Ulcerative Colitis: A Prospective Study

A. Bitton, P. Lakatos, G. Wild, 2021, Digestive Diseases and Sciences.

Assessing adherence to objective disease monitoring and outcomes with adalimumab in a real-world IBD cohort.

A. Cohen, A. Bitton, Y. Xiao, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A further "stri(v)de" in IBD management.

V. Annese, P. Lakatos, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

A Users Guide to De-escalating Immunomodulator and Biologic Therapy in Inflammatory Bowel Disease.

P. Lakatos, J. Halfvarson, J. Colombel, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Ver(s)ifying the efficacy of vedolizumab therapy on mucosal healing in Crohn's disease patients.

P. Lakatos, T. Bessissow, L. Gonczi, 2019, Gastroenterology.

Elderly patients with inflammatory bowel disease: Updated review of the therapeutic landscape

P. Lakatos, T. Bessissow, D. Wiseman, 2019, World journal of gastroenterology.

Clinical Parameters Correlate With Endoscopic Activity of Ulcerative Colitis: A Systematic Review.

A. Bitton, A. Barkun, E. Seidman, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Maladaptive coping, low self-efficacy and disease activity are associated with poorer patient-reported outcomes in inflammatory bowel disease

A. Bitton, C. Chao, P. Lakatos, 2019, Saudi journal of gastroenterology : official journal of the Saudi Gastroenterology Association.

Optimizing Patient Management in Crohn's Disease in a Tertiary Referral Center: the Impact of Fast-Track MRI on Patient Management and Outcomes.

P. Lakatos, G. Rudas, Z. Végh, 2018, Journal of gastrointestinal and liver diseases : JGLD.

Positioning of old and new biologicals and small molecules in the treatment of inflammatory bowel diseases

P. Lakatos, T. Bessissow, J. Reinglas, 2018, World journal of gastroenterology.

Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

K. Farkas, T. Molnár, P. Lakatos, 2014, The European Journal of Health Economics.

Erratum to: Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics

K. Farkas, T. Molnár, P. Lakatos, 2014, The European Journal of Health Economics.

Infliximab biosimilar CT-P13 therapy is effective in maintaining endoscopic remission in ulcerative colitis – results from multicenter observational cohort

K. Farkas, F. Nagy, T. Molnár, 2018, Expert opinion on biological therapy.

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.

K. Farkas, F. Nagy, T. Molnár, 2016, Journal of Crohn's & colitis.

Serum-"free"-thyroxine and triiodothyronine levels: their significance in preclinical hyperthyroidism and subclinical hypothyroidism.

P. Lakatos, A. Váradi, A. Gara, 1986, Acta medica Hungarica.

Serological biomarkers for management of primary sclerosing cholangitis

M. Papp, P. Lakatos, D. Tornai, 2022, World journal of gastroenterology.

Endothelin-1 actions on resorption, collagen and noncollagen protein synthesis, and phosphatidylinositol turnover in bone organ cultures.

P. Lakatos, P. Stern, G. Shankar, 1992, Endocrinology.

Serum leptin, soluble leptin receptor, free leptin index and bone mineral density in patients with primary biliary cirrhosis

P. Lakatos, A. Habior, I. Tornai, 2005, European journal of gastroenterology & hepatology.

The appropriate management of iron deficiency in patients with inflammatory bowel disease

C. Lees, M. Toruner, B. Moum, 2012 .

Plasma levels of C-type lectin REG3α and gut damage in people with HIV.

C. Tremblay, J. Routy, P. Lakatos, 2019, The Journal of infectious diseases.

Lack of association between interleukin-1 receptor antagonist protein gene polymorphism and bone mineral density in Hungarian postmenopausal women.

P. Lakatos, P. Vargha, É. Bajnok, 2000, Bone.

Association of Primary Biliary Cirrhosis with Vitamin D Receptor BsmI Genotype Polymorphism in a Hungarian Population

B. Halmos, G. Schmitz, L. Romics, 2000, Digestive Diseases and Sciences.

Gallium nitrate inhibits bone resorption and collagen synthesis in neonatal mouse calvariae

P. Lakatos, P. Stern, S. Mong, 1991, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Effects of 24 Months of Growth Hormone (GH) Treatment on Serum Carboxylated and Undercarboxylated Osteocalcin Levels in GH-Deficient Adults

K. Rácz, M. Tóth, L. Kovács, 2003, Calcified Tissue International.

High adherence to surveillance guidelines in IBD patients results in low colorectal cancer and dysplasia rates, while rates of dysplasia are low before the suggested onset of surveillance.

A. Bitton, E. Seidman, P. Lakatos, 2019, Journal of Crohn's & colitis.

Adenomatous polyps in ulcerative colitis and colonic Crohn’s disease: less frequent, but does this change surveillance strategy?

P. Lakatos, Z. Végh, Z. Kurti, 2016, Endoscopy.

Calcitonin and bone mass status in congenital hypothyroidism

P. Lakatos, G. Tarján, 1991, Calcified Tissue International.

[Decreased serum osteocalcin level in non-alcoholic and alcoholic chronic liver diseases].

P. Lakatos, B. Büki, F. Szalay, 1991, Orvosi hetilap.

Low bone mass in microscopic colitis

Z. Tulassay, P. Lakatos, P. Miheller, 2011, BMC gastroenterology.

Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy

Z. Tulassay, K. Rácz, P. Lakatos, 2007 .

Changes of OPG and RANKL concentrations in Crohn's disease after infliximab therapy.

Z. Tulassay, K. Rácz, P. Lakatos, 2007, Inflammatory Bowel Diseases.

Access to biologicals in Crohn’s disease in ten European countries

W. Groot, M. Pavlova, P. Lakatos, 2017, World journal of gastroenterology.

Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe

L. Peyrin-Biroulet, P. Lakatos, J. Halfvarson, 2017, Expert review of pharmacoeconomics & outcomes research.

New trends in inflammatory bowel disease epidemiology and disease course in Eastern Europe.

P. Lakatos, Z. Végh, P. Golovics, 2013, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[Epidemiology of inflammatory bowel diseases in Veszprém county of Western Hungary between 1977 and 2001].

P. Lakatos, L. Lakatos, Z. Erdélyi, 2003, Orvosi hetilap.

A Review of Mortality and Surgery in Ulcerative Colitis: Milestones of the Seriousness of the Disease

S. Ng, C. Bernstein, B. Moum, 2013, Inflammatory bowel diseases.

Circadian rhythm of in vitro bone-resorbing activity in human serum.

R. Eastell, P. Lakatos, P. Stern, 1995, The Journal of clinical endocrinology and metabolism.

[Changes in the epidemiology of inflammatory bowel diseases].

P. Lakatos, L. Lakatos, 2007, Orvosi hetilap.

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.

S. Bonovas, U. Kopylov, S. Sebastian, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Association of extraintestinal manifestations and anaemia with disease outcomes in patients with inflammatory bowel disease

G. Rogler, S. Vavricka, P. Lakatos, 2016, Scandinavian journal of gastroenterology.

Does Hospitalization Predict the Disease Course in Ulcerative Colitis? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Ulcerative Colitis in a Population-based Inception Cohort (2000-2012).

P. Lakatos, M. Mandel, L. Lakatos, 2015, Journal of gastrointestinal and liver diseases : JGLD.

Rediscovery of the Anti-Pancreatic Antibodies and Evaluation of their Prognostic Value in a Prospective Clinical Cohort of Crohn's Patients: The Importance of Specific Target Antigens [GP2 and CUZD1].

G. Veres, M. Papp, P. Lakatos, 2015, Journal of Crohn's & colitis.

Prevalence and predictors of hospitalization in Crohn's disease in a prospective population-based inception cohort from 2000-2012.

P. Lakatos, M. Mandel, L. Lakatos, 2015, World journal of gastroenterology.

Decreasing trends in hospitalizations during anti-TNF therapy are associated with time to anti-TNF therapy: Results from two referral centres.

K. Farkas, T. Molnár, P. Lakatos, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Frequency and prognostic role of mucosal healing in patients with Crohn's disease and ulcerative colitis after one-year of biological therapy.

K. Farkas, F. Nagy, T. Wittmann, 2014, World journal of gastroenterology.

The risk of lymphoma and immunomodulators in patients with inflammatory bowel diseases: results from a population-based cohort in Eastern Europe.

P. Lakatos, M. Szathmári, M. Mandel, 2013, Journal of Crohn's & colitis.

Is Current Smoking Still an Important Environmental Factor in Inflammatory Bowel Diseases? Results from a Population-based Incident Cohort

P. Lakatos, M. Szathmári, M. Mandel, 2013, Inflammatory bowel diseases.

Predictors of relapse in patients with Crohn's disease in remission after 1 year of biological therapy

K. Farkas, F. Nagy, T. Wittmann, 2013, Alimentary pharmacology & therapeutics.

Early clinical remission and normalisation of CRP are the strongest predictors of efficacy, mucosal healing and dose escalation during the first year of adalimumab therapy in Crohn’s disease

G. Veres, K. Farkas, F. Nagy, 2011, Alimentary pharmacology & therapeutics.

[Predictors of efficacy, mucosal healing and dose intensification during the first year of adalimumab therapy in patients with luminal and fistulizing Crohn's disease. National data from Hungary].

G. Veres, K. Farkas, F. Nagy, 2011, Orvosi Hetilap.

Risk of colorectal cancer and small bowel adenocarcinoma in Crohn's disease: a population-based study from western Hungary 1977-2008.

P. Lakatos, L. Lakatos, G. Dávid, 2011, Journal of Crohn's & colitis.

IBD in the elderly population: results from a population-based study in Western Hungary, 1977-2008.

P. Lakatos, L. Lakatos, G. Dávid, 2011, Journal of Crohn's & colitis.

Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis

M. Papp, P. Lakatos, J. Papp, 2010, European journal of gastroenterology & hepatology.

Anticarbohydrate antibodies as markers of inflammatory bowel disease in a Central European cohort

P. Lakatos, M. Lukáš, K. Malíčková, 2010, European journal of gastroenterology & hepatology.

Evaluation of the Combined Application of Ethanol-Fixed and Formaldehyde-Fixed Neutrophil Substrates for Identifying Atypical Perinuclear Antineutrophil Cytoplasmic Antibodies in Inflammatory Bowel Disease

G. Veres, M. Papp, P. Lakatos, 2009, Clinical and Vaccine Immunology.

Pancreatic autoantibodies are associated with reactivity to microbial antibodies, penetrating disease behavior, perianal disease, and extraintestinal manifestations, but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort.

G. Veres, T. Molnár, M. Papp, 2009, Inflammatory bowel diseases.

M1153 New Serological Markers for Inflammatory Bowel Disease Are Associated with Earlier Age At Onset, Complicated Disease Behavior, Risk for Surgery, and NOD2/CARD15 Genotype in a Hungarian IBD Cohort

T. Molnár, M. Papp, Z. Tulassay, 2008 .

Interaction between seroreactivity to microbial antigens and genetics in Crohn's disease: is there a role for defensins?

T. Molnár, M. Papp, Z. Tulassay, 2008, Tissue antigens.

Is the incidence and prevalence of inflammatory bowel diseases increasing in Eastern Europe?

P. Lakatos, L. Lakatos, 2006, Postgraduate Medical Journal.

Management of inflammatory bowel diseases in Eastern Europe

P. Lakatos, L. Lakatos, Peter L. Lakatos, 2006, Postgraduate Medical Journal.

Perceived Quality of Care is associated to disease activity, quality of life, work productivity and gender but not disease phenotype: a prospective study in a high-volume IBD center.

A. Bitton, E. Seidman, P. Lakatos, 2019, Journal of Crohn's & colitis.

Ulcerative proctitis: a review of pharmacotherapy and management

P. Lakatos, L. Lakatos, 2008, Expert opinion on pharmacotherapy.

ECCO Guidelines on Therapeutics in Ulcerative Colitis: Surgical Treatment.

J. Gisbert, S. Bonovas, E. Savarino, 2021, Journal of Crohn's & colitis.

[Epidemiology, predictors and clinical aspects of loss of response to biological therapy].

P. Lakatos, P. Miheller, K. Lőrinczy, 2012, Orvosi hetilap.

Anti-TNF trough levels and detection of antibodies to anti-TNF in inflammatory bowel disease: are they ready for everyday clinical use?

P. Lakatos, P. Miheller, L. Kiss, 2012, Expert opinion on biological therapy.

[Decreased bone mineral density and gene polymorphism in primary biliary cirrhosis].

P. Lakatos, I. Tornai, F. Szalay, 2004, Orvosi hetilap.

Immune phenotype in children with therapy-naïve remitted and relapsed Crohn's disease.

G. Veres, B. Vásárhelyi, T. Tulassay, 2010, World journal of gastroenterology.

Low Rate of Drug Discontinuation, Frequent Need for Dose Adjustment, and No Association with Development of New Arthralgia in Patients Treated with Vedolizumab: Results from a Tertiary Referral IBD Center

A. Bitton, E. Seidman, P. Lakatos, 2019, Digestive Diseases and Sciences.

Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection.

J. Maul, A. Schoepfer, G. Moran, 2010, Journal of Crohn's & colitis.

Ulcerative proctitis: an update on the pharmacotherapy and management

P. Lakatos, K. Gecse, 2014, Expert opinion on pharmacotherapy.

Natural history of ulcerative colitis: current knowledge.

P. Lakatos, L. Kiss, 2011, Current drug targets.

The efficacy of shortening the dosing interval to once every six weeks in Crohn’s patients losing response to maintenance dose of infliximab

U. Kopylov, G. Fiorino, P. Lakatos, 2011, Alimentary pharmacology & therapeutics.

Association of extraintestinal manifestations of inflammatory bowel disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study.

P. Lakatos, L. Lakatos, G. Dávid, 2003, World journal of gastroenterology.

Long-term selective estrogen receptor-beta agonist treatment modulates gene expression in bone and bone marrow of ovariectomized rats

J. Podani, P. Lakatos, Z. Liposits, 2019, The Journal of Steroid Biochemistry and Molecular Biology.

Therapeutic Drug Monitoring Guides the Management of Crohn's Patients with Secondary Loss of Response to Adalimumab.

A. Bitton, O. Kherad, C. Chao, 2018, Inflammatory bowel diseases.

Prediction of Short- and Medium-term Efficacy of Biosimilar Infliximab Therapy. Do Trough Levels and Antidrug Antibody Levels or Clinical And Biochemical Markers Play the More Important Role?

K. Farkas, T. Molnár, M. Papp, 2016, Journal of Crohn's & colitis.

Efficacy of Infliximab Biosimilar CT-P13 Induction Therapy on Mucosal Healing in Ulcerative Colitis.

K. Farkas, F. Nagy, T. Molnár, 2016, Journal of Crohn's & colitis.

P. Lakatos, L. Gonczi, Á. Iliás, 2018, Best practice & research. Clinical gastroenterology.

P. Lakatos, S. Ben-Horin, N. Vande Casteele, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Anti-TNF dose escalation and drug sustainability in Crohn's disease: Data from the nationwide administrative database in Hungary.

T. Molnár, P. Lakatos, K. Palatka, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Antibody and cell-mediated immune response to whole virion and split virion influenza vaccine in patients with inflammatory bowel disease on maintenance immunosuppressive and biological therapy

K. Farkas, F. Nagy, T. Wittmann, 2014, Scandinavian Journal of Gastroenterology.

Clinical Risk Factors: Lessons from Epidemiology

P. Lakatos, Z. Végh, Z. Kurti, 2019, Biomarkers in Inflammatory Bowel Diseases.

Su1331 Is Hospitalization Predicting the Disease Course in Crohn's Disease? Prevalence and Predictors of Hospitalization and Re-Hospitalization in Crohn's Disease in a Population Based Inception Cohort Between 2000-2012

P. Lakatos, M. Mandel, L. Lakatos, 2014 .

Comparative Effectiveness of Infliximab Versus Adalimumab in Patients with Biologic-Naïve Crohn’s Disease

A. Bitton, U. Kopylov, P. Lakatos, 2018, Digestive Diseases and Sciences.

Optimizing biological therapy in Crohn’s disease

P. Lakatos, K. Gecse, Z. Végh, 2016, Expert review of gastroenterology & hepatology.

Predictors of relapse in patients with ulcerative colitis in remission after one-year of infliximab therapy

K. Farkas, F. Nagy, T. Wittmann, 2013, Scandinavian journal of gastroenterology.

S1201 IBD in the Elderly Population, Prevalence and Disease Course in Western Hungary Between 1977-2008

P. Lakatos, L. Lakatos, G. Dávid, 2010 .

Thiopurines in Crohn's disease, is there something new?

P. Lakatos, P. Miheller, 2010, Expert opinion on drug metabolism & toxicology.

[Anti-TNF-alpha therapy in ulcerative colitis].

P. Lakatos, L. Lakatos, 2008, Orvosi hetilap.

Patient Perspectives and Expectations in Inflammatory Bowel Disease: A Systematic Review

P. Lakatos, W. Afif, T. Bessissow, 2021, Digestive Diseases and Sciences.

Epidemiological data and utilization patterns of anti-TNF alpha therapy in the Hungarian ulcerative colitis population between 2012-2016

K. Farkas, T. Molnár, P. Lakatos, 2020, Expert opinion on biological therapy.

Diagnostic yield of upper endoscopy in paediatric patients with Crohn's disease and ulcerative colitis. Subanalysis of the HUPIR registry.

G. Veres, M. Papp, P. Lakatos, 2012, Journal of Crohn's & colitis.

Endoscopic management of Crohn’s strictures

G. Van Assche, P. Lakatos, A. Aruljothy, 2018, World journal of gastroenterology.

Patterns in the Diagnosis and Treatment of Osteoporosis in Men: A Questionnaire-based Survey in Central and Eastern European Countries

M. Boyanov, P. Lakatos, C. Poiană, 2017 .

Reply to Letter on: 'Risk Factors Associated With Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-analysis'.

A. Bitton, P. Lakatos, W. Afif, 2018, Journal of Crohn's & colitis.

[Relevance of serologic studies in inflammatory bowel diseases].

M. Papp, P. Lakatos, I. Altorjay, 2007, Orvosi hetilap.

Utility of serological markers in inflammatory bowel diseases: gadget or magic?

M. Papp, P. Lakatos, G. Norman, 2007, World journal of gastroenterology.

New approach to analyze genetic and clinical data in bisphosphonate-induced osteonecrosis of the jaw.

J. Podani, P. Lakatos, Á. Lazáry, 2012, Oral diseases.

The Burden of Anemia Remains Significant over Time in Patients with Inflammatory Bowel Diseases at a Tertiary Referral Center.

A. Bitton, P. Lakatos, G. Wild, 2020, Journal of gastrointestinal and liver diseases : JGLD.

Serum dipeptidyl peptidase IV (DPP IV, CD26) activity in chronic hepatitis C.

P. Lakatos, F. Szalay, G. Firneisz, 2001, Scandinavian journal of gastroenterology.

[Urinary calcium excretion. (Normal values for urinary calcium/creatinine ratio in Hungary). Multicenter study].

P. Lakatos, B. Büki, J. Németh, 1997, Orvosi hetilap.

Evidence or eminence: optimising patient outcomes by choosing the right doctor?

G. Veres, P. Lakatos, 2012, Gut.

A Multicentre, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, and Tolerability of the S1P Receptor Agonist KRP203 in Patients with Moderately Active Refractory Ulcerative Colitis

G. Rogler, G. Van Assche, P. Lakatos, 2020, Inflammatory Intestinal Diseases.

Antigenic response to CT‐P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition

João Paulo N. Torres, G. D'Haens, T. Dörner, 2018, Alimentary pharmacology & therapeutics.

Long-term Efficacy, Safety, and Immunogenicity of Biosimilar Infliximab After One Year in a Prospective Nationwide Cohort

K. Farkas, F. Nagy, T. Molnár, 2017, Inflammatory bowel diseases.

Doubling the infliximab dose versus halving the infusion intervals in Crohn's disease patients with loss of response

J. Gisbert, P. Higgins, A. Hart, 2012, Inflammatory bowel diseases.

Current status of thiopurine analogues in the treatment in Crohn's disease.

P. Lakatos, L. Kiss, 2011, World journal of gastroenterology.

Identifying novel genes involved in both deer physiological and human pathological osteoporosis

T. Vellai, A. Borsy, J. Podani, 2009, Molecular Genetics and Genomics.

Anti-TNF Therapy and the Risk of Herpes Zoster Among Patients With Inflammatory Bowel Disease.

A. Bitton, P. Lakatos, T. Bessissow, 2021, Inflammatory bowel diseases.

Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism.

P. Lakatos, C. Horváth, J. Földes, 1997, European journal of endocrinology.

Rising plasma nociceptin level during development of HCC: a case report.

P. Lakatos, F. Szalay, A. Folhoffer, 2004, World journal of gastroenterology.

Incidence, Predictive Factors, Clinical Characteristics and Outcome of Non-variceal Upper Gastrointestinal Bleeding - A Prospective Population-based Study from Hungary.

P. Lakatos, B. Gasztonyi, I. Rácz, 2021, Journal of gastrointestinal and liver diseases : JGLD.

Dose optimization is effective in ulcerative colitis patients losing response to infliximab: a collaborative multicentre retrospective study.

U. Kopylov, G. Fiorino, P. Lakatos, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

The NOD2-Smoking Interaction in Crohn's Disease is likely Specific to the 1007 fs Mutation and may be Explained by Age at Diagnosis: A Meta-Analysis and Case-Only Study

G. Kaplan, M. Silverberg, H. Barkema, 2017, EBioMedicine.

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

L. French, G. Rogler, A. Schoepfer, 2015, Inflammatory bowel diseases.

Unoprostone Isopropyl Pretreatment Decreases Endothelin-1 Release and the Intra-Ocular Pressure Spike Induced by Laser Trabeculoplasty in the Rabbit

P. Lakatos, G. Holló, P. Vargha, 2003, Ophthalmologica.

Endothelin-A Receptor Antagonist BQ-485 Protects against Intraocular Pressure Spike Induced by Laser Trabeculoplasty in the Rabbit

P. Kóthy, P. Lakatos, G. Holló, 2002, Ophthalmologica.

Immediate Increase in Aqueous Humour Endothelin 1 Concentration and Intra-Ocular Pressure after Argon Laser Trabeculoplasty in the Rabbit

P. Lakatos, G. Holló, P. Vargha, 2000, Ophthalmologica.

Increase of endothelin-1 concentration in aqueous humour induced by argon laser trabeculoplasty in the rabbit. A preliminary study.

P. Lakatos, G. Holló, 1998, Acta ophthalmologica Scandinavica.

[Review of the application of synthetic bone grafts. The role of the gypsum in bone substitution: molecular biological approach, based on own research results].

P. Lakatos, Á. Lazáry, B. Balla, 2007, Orvosi Hetilap.

Effect of vertebroplasty filler materials on viability and gene expression of human nucleus pulposus cells

P. Lakatos, Á. Lazáry, B. Balla, 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

Thyroid Hormones, Glucocorticoids, Insulin, and Bone.

P. Lakatos, I. Takács, Z. Putz, 2020, Handbook of experimental pharmacology.

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

G. Veres, M. Papp, P. Lakatos, 2013, Journal of hepatology.

Location and age at onset of colorectal cancer in Hungarian patients between 1993 and 2004. The high number of advanced cases supports the need for a colorectal cancer screening program in Hungary.

E. Hitre, P. Lakatos, J. Papp, 2006, Anticancer research.

Effects of cyclosporins and transforming growth factor β1 on thyroid hormone action in cultured fetal rat limb bones

P. Lakatos, P. Stern, 1992, Calcified Tissue International.

Clinical relevance of changes in bone metabolism in inflammatory bowel disease.

P. Lakatos, P. Miheller, K. Lőrinczy, 2010, World journal of gastroenterology.

Nutritional Influences in Selected Gastrointestinal Diseases

P. Lakatos, P. Miheller, L. Kiss, 2011, Digestive Diseases.

The burden of inflammatory bowel disease in Europe in 2020.

P. Lakatos, J. Burisch, Mirabella Zhao, 2021, Journal of Crohn's & colitis.

Sex-Based Differences in Incidence of Inflammatory Bowel Diseases-Pooled Analysis of Population-Based Studies From Western Countries.

S. Ng, G. Kaplan, A. Bitton, 2018, Gastroenterology.

[The role of fecal calprotectin in the diagnosis and treatment of gastrointestinal diseases].

P. Lakatos, B. Lovász, Á. Iliás, 2019, Orvosi hetilap.

Gene expression dynamics in deer antler: mesenchymal differentiation toward chondrogenesis

L. Puskás, A. Borsy, F. Deák, 2007, Molecular Genetics and Genomics.

NOD1 gene E266K polymorphism is associated with disease susceptibility but not with disease phenotype or NOD2/CARD15 in Hungarian patients with Crohn's disease.

F. Nagy, T. Molnár, M. Papp, 2007, Digestive and Liver Disease.

Vitamin D Receptor Gene BsmI Polymorphism Correlates with erbB-2/HER-2 Expression in Human Rectal Cancer

M. Kucsera, Z. Bori, P. Lakatos, 2000, Oncology.

Geographical variability and environmental risk factors in inflammatory bowel disease

S. Ng, C. O'Morain, M. Vatn, 2013, Gut.

Adalimumab monotherapy versus combination therapy with immunomodulators in patients with Crohn's disease: a systematic review and meta-analysis.

A. Bitton, E. Seidman, U. Kopylov, 2014, Journal of Crohn's & colitis.

Risk factors for complications in patients with ulcerative colitis

J. Borovička, G. Rogler, S. Vavricka, 2016, United European gastroenterology journal.

Efficacy and safety of infliximab induction therapy in Crohn's Disease in Central Europe - a Hungarian nationwide observational study

F. Nagy, T. Molnár, M. Papp, 2009, BMC gastroenterology.

Risk for colorectal cancer in ulcerative colitis: changes, causes and management strategies.

P. Lakatos, L. Lakatos, 2008, World journal of gastroenterology.

Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2014, Journal of Crohn's & colitis.

Incidence rates and disease course of paediatric inflammatory bowel diseases in Western Hungary between 1977 and 2011.

G. Veres, P. Lakatos, M. Mandel, 2014, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Mucocele of the appendix: an unusual cause of lower abdominal pain in a patient with ulcerative colitis. A case report and review of literature.

P. Lakatos, J. Papp, J. Halász, 2005, World journal of gastroenterology.

Mucocele of the appendix: An unusual cause of lower abdominal pain in a patient with ulcerative colitis

P. Lakatos, J. Papp, J. Halász, 2004 .

Epidemiology and Diagnosis of Hypoparathyroidism.

E. Brown, J. Bilezikian, R. Thakker, 2016, The Journal of clinical endocrinology and metabolism.

Cancer in inflammatory bowel disease 15 years after diagnosis in a population-based European Collaborative follow-up study.

S. Vermeire, A. Tatsioni, B. Moum, 2011, Journal of Crohn's & colitis.

Effects of imatinib and nilotinib on the whole transcriptome of cultured murine osteoblasts

P. Horváth, P. Lakatos, B. Balla, 2016, Molecular medicine reports.

Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.

S. Mohan, P. Lakatos, P. Stern, 2000, Thyroid : official journal of the American Thyroid Association.

Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis.

S. Cummings, S. Boonen, J. Cauley, 2007, The New England journal of medicine.

Transcriptional profiling of immune system-related genes in postmenopausal osteoporotic versus non-osteoporotic human bone tissue.

J. Podani, P. Lakatos, Á. Lazáry, 2009, Clinical immunology.

INFLAMMATORY BOWEL DISEASES: Genetic Markers and their Use in Predicting Disease Course, Response to Treatment, and Need for Surgery

P. Lakatos, S. Fischer, 2008 .

ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases

A. Tordai, T. Molnár, M. Papp, 2007, Scandinavian journal of gastroenterology.

The Use of Balloon-assisted Enteroscopy at a Large Volume Centre: A Retrospective Analysis

A. Barkun, P. Lakatos, T. Bessissow, 2018, Journal of the Canadian Association of Gastroenterology.

Double balloon enteroscopy examinations in general anesthesia.

P. Lakatos, J. Papp, L. Zubek, 2010, World journal of gastroenterology.

[Double-balloon endoscopy for the diagnosis and treatment of small intestinal disease: an initial experience from 25 examinations].

P. Lakatos, J. Papp, L. Zubek, 2006, Orvosi hetilap.

Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection

J. Féher, H. Blum, P. Lakatos, 2011, Hepatitis monthly.

Initial Disease Course and Treatment in an Inflammatory Bowel Disease Inception Cohort in Europe: The ECCO-EpiCom Cohort

C. O'Morain, V. Andersen, L. Kupčinskas, 2014, Inflammatory bowel diseases.

Targeted Mutational Profiling and a Powerful Risk Score as Additional Tools for the Diagnosis of Papillary Thyroid Cancer

J. Podani, P. Lakatos, B. Balla, 2019, Pathology & Oncology Research.

[Colonic diverticular disease: diagnosis and therapy].

P. Lakatos, L. Lakatos, 2012, Orvosi hetilap.

Calcium-sensing receptor A986S polymorphism in human rectal cancer

A. Tislér, I. Mucsi, P. Lakatos, 2002, International Journal of Colorectal Disease.

[The role of estrogen receptor, vitamin D receptor and calcium receptor genotypes in the pathogenesis of colorectal cancer].

P. Lakatos, P. Vargha, K. Cseh, 2001, Orvosi hetilap.

Gut barrier failure biomarkers are associated with poor disease outcome in patients with primary sclerosing cholangitis

G. Veres, M. Papp, P. Orosz, 2017, World journal of gastroenterology.

Environment and invironment in IBDs: partners in crime

P. Lakatos, J. Burisch, Johan Burisch, 2014, Gut.

Gender-stratified analysis of DLG5 R30Q in 4707 patients with Crohn disease and 4973 controls from 12 Caucasian cohorts

M. Tremelling, M. Parkes, H. Drummond, 2007, Journal of Medical Genetics.

Effect of menopause on gene expression pattern in bone tissue of nonosteoporotic women

A. Borsy, J. Podani, P. Lakatos, 2009, Menopause.

Therapy of Steroid-Resistant Inflammatory Bowel Disease

G. Rogler, A. Schoepfer, S. Vavricka, 2012, Digestion.

[Medical therapy of inflammatory bowel diseases: Crohn's disease].

P. Lakatos, L. Lakatos, 2007, Orvosi hetilap.

The Future of Biosimilars: Maximizing Benefits Across Immune-Mediated Inflammatory Diseases

S. Simoens, J. Jeong, J. Jahnsen, 2020, Drugs.

Has There Been a Change in the Natural History of Crohn's Disease? Surgical Rates and Medical Management in a Population-Based Inception Cohort from Western Hungary Between 1977–2009

G. Veres, P. Lakatos, M. Szathmári, 2012, The American Journal of Gastroenterology.

Smoking in inflammatory bowel diseases: good, bad or ugly?

P. Lakatos, L. Lakatos, T. Szamosi, 2007, World journal of gastroenterology.

[Medical therapy of inflammatory bowel diseases: ulcerative colitis].

P. Lakatos, L. Lakatos, 2007, Orvosi hetilap.

Risk factors for ulcerative colitis‐associated colorectal cancer in a Hungarian cohort of patients with ulcerative colitis: Results of a population‐based study

P. Lakatos, P. Vargha, L. Lakatos, 2006, Inflammatory bowel diseases.

Results of the 2nd part Scientific Workshop of the ECCO. II: Measures and markers of prediction to achieve, detect, and monitor intestinal healing in inflammatory bowel disease.

M. Färkkilä, I. Dotan, P. Lakatos, 2011, Journal of Crohn's & colitis.

[Postoperative recurrence of Crohn's disease, and its prevention].

P. Lakatos, L. Lakatos, 2010, Orvosi hetilap.

Genetics, Immunology and biomarkers in clinical practice: do they assist in clinical management?

P. Lakatos, 2008 .

Guideline / Consensus Paper 3 rd European Evidence-based Consensus on the Diagnosis and Management of Crohn ’ s Disease 2016 : Part 2 : Surgical Management and Special Situations

C. Buskens, G. Rogler, S. Vavricka, 2017 .

Use of new once-daily 5-aminosalicylic acid preparations in the treatment of ulcerative colitis: Is there anything new under the sun?

P. Lakatos, 2009, World journal of gastroenterology.

[Effectiveness of new, once-daily 5-aminosalicylic acid in the treatment of ulcerative colitis].

P. Lakatos, L. Lakatos, 2009, Orvosi hetilap.

Once daily 5-aminosalicylic acid for the treatment of ulcerative colitis; are we there yet?

P. Lakatos, L. Lakatos, 2008, Pharmacological research.

Is early limited surgery associated with a more benign disease course in Crohn's disease?

G. Veres, P. Lakatos, M. Mandel, 2013, World journal of gastroenterology.

Quality of care in inflammatory bowel diseases: What is the best way to better outcomes?

P. Lakatos, T. Bessissow, M. Strohl, 2018, World journal of gastroenterology.

C. O'Morain, E. Björnsson, V. Andersen, 2014, Journal of Crohn's & colitis.

Mucosal healing and deep remission: what does it mean?

G. Rogler, A. Schoepfer, S. Vavricka, 2013, World journal of gastroenterology.

Nonadherence in inflammatory bowel disease: Results of factor analysis

P. Lakatos, A. Kuběna, M. Lukáš, 2007, Inflammatory bowel diseases.

Current concept on the pathogenesis of inflammatory bowel disease-crosstalk between genetic and microbial factors: pathogenic bacteria and altered bacterial sensing or changes in mucosal integrity take "toll" ?

P. Lakatos, J. Papp, L. Lakatos, 2006, World journal of gastroenterology.

Genetic and microbial factors modulating the ubiquitin proteasome system in inflammatory bowel disease

C. Wijmenga, T. Ahmad, P. Rutgeerts, 2013, Gut.

Risk Factors Associated with Clostridium difficile Infection in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

A. Bitton, P. Lakatos, W. Afif, 2018, Journal of Crohn's & colitis.

Risk of colorectal cancer in Crohn's disease patients with colonic involvement and stenosing disease in a population-based cohort from Hungary.

P. Lakatos, M. Mandel, L. Lakatos, 2013, Journal of gastrointestinal and liver diseases : JGLD.

Accuracy of amplitude‐integrated electroencephalography in the prediction of neurodevelopmental outcome in asphyxiated infants receiving hypothermia treatment

P. Lakatos, M. Bangó, A. Csekő, 2013, Acta paediatrica.

Serum Anti-Saccharomyces Cerevisiae Antibodies in Greek Patients with Behcet's Disease

M. Papp, P. Lakatos, G. Vaiopoulos, 2011, Yonsei medical journal.

Poor Drug Sustainability in Inflammatory Bowel Disease Patients in Clinical Remission on Thiopurine Monotherapy

A. Bitton, P. Lakatos, G. Wild, 2020, Digestive Diseases and Sciences.

Loss of tolerance to gut immunity protein, glycoprotein 2 (GP2) is associated with progressive disease course in primary sclerosing cholangitis

G. Veres, M. Papp, P. Lakatos, 2018, Scientific Reports.

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

V. Andersen, L. Kupčinskas, S. Sebastian, 2018, Gut.

Pregnancy outcome in patients with inflammatory bowel disease according to the activity of the disease and the medical treatment: A case–control study

K. Farkas, F. Nagy, T. Wittmann, 2010, Scandinavian journal of gastroenterology.

P623 Therapeutic preferences and outcomes in newly diagnosed patient with inflammatory bowel diseases in the biological era in Hungary. A nationwide study based on the National Health Insurance Fund database.

P. Lakatos, K. Gecse, Z. Végh, 2017, Journal of Crohn's & colitis.

Novel Genetic Mutation in the Background of Carney Complex

P. Lakatos, A. Patócs, H. Butz, 2012, Pathology & Oncology Research.

[Novel mutation in a patient with Carney complex].

P. Lakatos, A. Patócs, I. Takács, 2011, Orvosi hetilap.

Evolution of disease phenotype in adult and pediatric onset Crohn's disease in a population-based cohort.

P. Lakatos, M. Mandel, L. Lakatos, 2013, World journal of gastroenterology.

Recommendations for identifying Crohn’s disease patients with poor prognosis

P. Lakatos, M. Mandel, P. Miheller, 2013, Expert review of clinical immunology.

Results of the 2 nd part Scientific Workshop of the ECCO ( II ) : Measures and markers of prediction to achieve , detect , and monitor intestinal healing in Inflammatory Bowel Disease

M. Färkkilä, I. Dotan, P. Lakatos, 2011 .

[Extra-intestinal manifestation of IBD in Veszprém county (of Hungary): results of a 25-years follow-up study].

P. Lakatos, L. Lakatos, G. Dávid, 2003, Orvosi hetilap.

Concordance between tuberculin skin test and interferon-gamma release assay for latent tuberculosis screening in inflammatory bowel disease

P. Lakatos, W. Afif, T. Bessissow, 2020, Intestinal research.

Single nucleotide polymorphisms in new candidate genes are associated with bone mineral density and fracture risk.

István Takács, Péter Lakatos, Zsolt Nagy, 2008, European journal of endocrinology.

Progress with infliximab biosimilars for inflammatory bowel disease

P. Lakatos, Z. Kurti, L. Gonczi, 2018, Expert opinion on biological therapy.

Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?

P. Lakatos, T. Bessissow, L. Gonczi, 2019, World journal of gastroenterology.

Cost-effectiveness of biological treatment sequences for fistulising Crohn’s disease across Europe

L. Peyrin-Biroulet, P. Lakatos, S. Danese, 2018, United European gastroenterology journal.

Presence of Anti-Microbial Antibodies in Liver Cirrhosis – A Tell-Tale Sign of Compromised Immunity?

G. Veres, M. Papp, P. Orosz, 2010, PloS one.

Drug persistence and need for dose intensification to adalimumab therapy; the importance of therapeutic drug monitoring in inflammatory bowel diseases

K. Farkas, T. Molnár, P. Lakatos, 2017, BMC Gastroenterology.

Haptoglobin polymorphism: a novel genetic risk factor for celiac disease development and its clinical manifestations.

G. Veres, I. Korponay-Szabó, M. Papp, 2008, Clinical chemistry.

Recombinant Human Parathyroid Hormone Effect on Health-Related Quality of Life in Adults With Chronic Hypoparathyroidism

J. Bilezikian, D. Shoback, P. Lakatos, 2017, The Journal of clinical endocrinology and metabolism.

Faecal Calprotectin Predicts Endoscopic and Histological Activity in Clinically Quiescent Ulcerative Colitis.

A. Bitton, O. Kherad, P. Lakatos, 2019, Journal of Crohn's & colitis.

Time to onset of bisphosphonate-related osteonecrosis of the jaws: a multicentre retrospective cohort study.

S. Rogers, G. Bedogni, M. Pirmohamed, 2017, Oral diseases.

Serum lipopolysaccharide‐binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease

G. Veres, K. Farkas, T. Molnár, 2011, Inflammatory bowel diseases.

Congress Report: 5th Central and Eastern Europe (CEE) Summit on Osteoporosis in Bratislava, 2–3 December 2011

J. Bilezikian, P. Lakatos, H. Resch, 2013, Archives of Osteoporosis.

The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study

J. Reginster, C. Roux, E. Franek, 2015, Osteoporosis International.

Gene expression patterns in the bone tissue of women with fibrous dysplasia

A. Borsy, J. Podani, P. Lakatos, 2010, American journal of medical genetics. Part A.

The Effect of 3 Versus 6 Years of Zoledronic Acid Treatment of Osteoporosis: A Randomized Extension to the HORIZON-Pivotal Fracture Trial (PFT)

S. Cummings, S. Boonen, J. Cauley, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Spectrum of Thyroid Gland Pathology in Carney Complex: The Importance of Follicular Carcinoma

R. Seethala, C. Stratakis, A. Perez-Atayde, 2017, The American journal of surgical pathology.

Marked increase of CYP24A1 mRNA level in hepatocellular carcinoma cell lines following vitamin D administration.

I. Kovalszky, P. Lakatos, F. Szalay, 2012, Anticancer research.

Postmenopausal Expression Changes of Immune System-Related Genes in Human Bone Tissue

J. Podani, P. Lakatos, Á. Lazáry, 2009, Journal of Clinical Immunology.

Characterization of and risk factors for the acute-phase response after zoledronic acid.

I. Reid, D. Black, G. Gamble, 2010, The Journal of clinical endocrinology and metabolism.

[The effect of early immunosuppressive therapy on the rate of resections performed in patients with Chron's disease, in Veszprém county, Hungary, a population-based cohort study].

P. Lakatos, M. Szathmári, L. Lakatos, 2012, Orvosi hetilap.

Burden of Clostridium difficile infection between 2010 and 2013: Trends and outcomes from an academic center in Eastern Europe.

P. Lakatos, M. Szathmári, M. Mandel, 2015, World Journal of Gastroenterology.

Long term efficacy of radioiodine treatment in hyperthyroidism.

P. Lakatos, B. Balla, I. Takács, 2013, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

Gene Expression Changes in Femoral Head Necrosis of Human Bone Tissue

J. Podani, P. Lakatos, C. Pinter, 2011, Disease markers.

Different Gene Expression Patterns in the Bone Tissue of Aging Postmenopausal Osteoporotic and Non-osteoporotic Women

A. Borsy, J. Podani, P. Lakatos, 2007, Calcified Tissue International.

Presence of class IGA anti-neutrophil cytoplasmic antibodies (ANCA) in cirrhosis – A tell-tale sign of compromised mucosal immunity?

M. Papp, P. Lakatos, I. Tornai, 2012 .

AN OPEN-LABEL EXTENSION STUDY OF PARATHYROID HORMONE RHPTH(1-84) IN ADULTS WITH HYPOPARATHYROIDISM.

P. Lakatos, L. Bajnok, H. Lagast, 2016, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

Risk of malignant cancers in inflammatory bowel disease.

A. Bitton, S. Suissa, P. Lakatos, 2019, Journal of Crohn's & colitis.

Editorial: co‐existing immune‐mediated disease in inflammatory bowel diseases – a new disease severity indicator?

P. Lakatos, W. Afif, T. Bessissow, 2017, Alimentary pharmacology & therapeutics.

[Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].

P. Lakatos, P. Vargha, L. Lakatos, 2006, Orvosi Hetilap.

Patient and general population values for luminal and perianal fistulising Crohn’s disease health states

P. Lakatos, P. Stalmeier, M. Péntek, 2019, The European Journal of Health Economics.

Cold pressor test and plasma endothelin-1 concentration in primary open-angle and capsular glaucoma.

P. Lakatos, G. Holló, K. Farkas, 1998, Journal of glaucoma.

Vitamin D and estrogen receptor gene polymorphisms in type 2 diabetes mellitus and in android type obesity.

P. Lakatos, G. Winkler, P. Vargha, 2001, European journal of endocrinology.

Outcomes of Patients With Inflammatory Bowel Diseases Switched From Maintenance Therapy With a Biosimilar to Remicade.

K. Farkas, T. Molnár, P. Lakatos, 2019, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

P545 Antigenic response to CT-P13 and remicade in inflammatory bowel disease patients shows similar epitope recognition

G. D'Haens, T. Dörner, G. Fiorino, 2018 .

Validity of the EQ-5D-5L and EQ-5D-3L in patients with Crohn’s disease

T. Molnár, P. Lakatos, M. Péntek, 2018, Quality of Life Research.

Prediction of disease course in inflammatory bowel diseases.

P. Lakatos, 2010, World Journal of Gastroenterology.

‘Treat to Target' - Lessons Learnt

P. Lakatos, Z. Végh, P. Golovics, 2016, Digestive Diseases.

Anti-TNFs and severe infections in autoimmune diseases: the other side of the coin.

P. Lakatos, 2012, Inflammatory Bowel Diseases.

High‐sensitivity C‐reactive protein for identification of disease phenotype, active disease, and clinical relapses in Crohn's disease: A marker for patient classification?

M. Papp, P. Lakatos, M. Szathmári, 2012, Inflammatory bowel diseases.

Development of Red Flags Index for Early Referral of Adults with Symptoms and Signs Suggestive of Crohn's Disease: An IOIBD Initiative.

S. Vermeire, L. Moja, S. Travis, 2014, Journal of Crohn's & colitis.

[Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease].

G. Veres, M. Papp, P. Lakatos, 2013, Orvosi hetilap.

High-Dose Infliximab Rescue Therapy for Hospitalized Acute Severe Ulcerative Colitis Does Not Improve Colectomy-Free Survival

A. Bitton, C. Chao, P. Lakatos, 2018, Digestive Diseases and Sciences.

Frequency and characteristics of infusion reactions during biosimilar infliximab treatment in inflammatory bowel diseases: results from Central European nationwide cohort

K. Farkas, F. Nagy, T. Molnár, 2017, Expert opinion on drug safety.

IBD in 2016: Biologicals and biosimilars in IBD — the road to personalized treatment

P. Lakatos, K. Gecse, 2017, Nature Reviews Gastroenterology &Hepatology.

Tu1962 Looking Beyond Symptoms and Disease Activity to Define Disease Severity in Inflammatory Bowel Disease: Results of an IOIBD Specialist Panel

S. Ng, C. O'Morain, M. Silverberg, 2016 .

[Changes of gene expression and its role in pathogenesis in fibrous and non-fibrous dysplastic bone tissues in women].

A. Borsy, J. Podani, P. Lakatos, 2010, Orvosi hetilap.

Management of inflammatory bowel diseases: a changing paradigm. Can we finally change the disease course?

P. Lakatos, 2010, Inflammatory bowel diseases.

[NOD2/CARD15 mutations and genotype-phenotype correlations in patients with Crohn's disease. Hungarian multicenter study].

T. Molnár, Z. Tulassay, W. Reinisch, 2004, Orvosi hetilap.

Natural Disease Course of Ulcerative Colitis During the First Five Years of Follow-up in a European Population-based Inception Cohort—An Epi-IBD Study

V. Andersen, L. Kupčinskas, S. Sebastian, 2018, Journal of Crohn's & colitis.

P694 Disease course during the first five years following diagnosis in a prospective European population-based inception cohort - the ECCO-EpiCom cohort.

L. Kupčinskas, J. Dahlerup, P. Lakatos, 2017, Journal of Crohn's & colitis.

Endothelin concentrations are elevated in plasma of patients with primary and secondary hyperparathyroidism

P. Lakatos, P. Stern, C. Horváth, 2006, Calcified Tissue International.

P. Lakatos, Z. Kurti, L. Gonczi, 2019, Current pharmaceutical design.

Mo1843 - Non-Medical Mandatory Reversed and Back and Forth Switch Between Infliximab and its Biosimilar: Early Clinical Outcomes

K. Farkas, T. Molnár, P. Lakatos, 2018 .

P694 Non-medical mandatory reversed and back and forth switch between infliximab and its biosimilar: Early clinical outcomes

T. Molnár, P. Lakatos, Z. Szepes, 2018 .

Final Results on Immunogenicity Profile and Predictors of ADA Development of Biosimilar Infliximab During the First 12 Months of the Therapy: Results from a Prospective Nationwide Cohort

K. Farkas, T. Molnár, M. Papp, 2017 .

P592 Final results on immunogenicity profile and predictors of ADA development of biosimilar infliximab during the first 12 months of the therapy: results from a prospective nationwide cohort.

T. Molnár, M. Papp, P. Lakatos, 2017, Journal of Crohn's & colitis.

P331 Final results on efficacy and safety of biosimilar infliximab after one-year: results from a prospective nationwide cohort.

F. Nagy, T. Molnár, M. Papp, 2017, Journal of Crohn's & colitis.

Sa1936 Efficacy and Safety of Biosimilar Infliximab After One-Year: Results From a Prospective Nationwide Cohort

K. Farkas, T. Molnár, P. Lakatos, 2016 .

Editorial: antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars. Authors’ reply

P. Lakatos, S. Danese, S. Ben-Horin, 2018, Alimentary pharmacology & therapeutics.

Real-Life Efficacy, Immunogenicity and Safety of Biosimilar Infliximab

P. Lakatos, Z. Végh, Z. Kurti, 2017, Digestive Diseases.

Subjective expectations regarding longevity and future health: a cross‐sectional survey among patients with Crohn's disease

P. Lakatos, M. Péntek, V. Brodszky, 2020, Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland.

Is There a Change in the Natural History of Crohn's Disease; Surgical Rates and Medical Management in a Population-Based Inception Cohort From Western Hungary Between 1977-2008

P. Lakatos, L. Lakatos, Z. Erdélyi, 2011 .

The 3′UTR NFKBIA Variant Is Associated with Extensive Colitis in Hungarian IBD Patients

A. Tordai, T. Molnár, M. Papp, 2009, Digestive Diseases and Sciences.

Comparative statistical analysis of osteoporosis treatment based on Hungarian claims data and interpretation of the results in respect to cost-effectiveness

P. Lakatos, I. Takács, L. Szekeres, 2014, Osteoporosis International.

Letter: European Medicines Agency recommendations for allergic reactions to intravenous iron‐containing medicines

C. Lees, M. Toruner, B. Moum, 2014, Alimentary pharmacology & therapeutics.

Mannose-binding lectin deficiency confers risk for bacterial infections in a large Hungarian cohort of patients with liver cirrhosis.

M. Papp, P. Orosz, P. Lakatos, 2010, Journal of hepatology.

Coexistence of a pancreatic serous cystadenoma and a VIP-producing neuroendocrine tumor

J. Tímár, P. Lakatos, A. Patócs, 2015 .

Aortic Stiffening Is an Extraintestinal Manifestation of Inflammatory Bowel Disease: Review of the Literature and Expert Panel Statement

D. Mikhailidis, I. Wilkinson, P. Boutouyrie, 2020, Angiology.

[Surgery of primary hyperparathyroidism].

P. Lakatos, J. Horányi, T. Györke, 2006, Orvosi hetilap.

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

P. Geusens, E. Lespessailles, P. López-Romero, 2017, The Lancet.

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study

M. Drezner, C. Cooper, C. Christiansen, 2005, Annals of the rheumatic diseases.

Denosumab significantly increases DXA BMD at both trabecular and cortical sites: results from the FREEDOM study.

M. Brandi, P. Lakatos, A. Høiseth, 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Effects of Teriparatide Compared with Risedronate on the Risk of Fractures in Subgroups of Postmenopausal Women with Severe Osteoporosis: The VERO Trial

P. Geusens, E. Lespessailles, P. López-Romero, 2018, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels

M. Tóth, P. Lakatos, J. Horányi, 2003, Journal of endocrinological investigation.

Next-generation Sequencing in the Clinical Decision Making in Hypertrophic Cardiomyopathy

B. Merkely, P. Lakatos, I. Likó, 2017 .

A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary

M. Intorcia, P. Lakatos, I. Takács, 2016, Calcified Tissue International.

[Verner-Morrison syndrome: a case study].

P. Lakatos, A. Patócs, Z. Nagy, 2010, Orvosi hetilap.

Association of peroxisome proliferator‐activated receptor gamma polymorphisms with inflammatory bowel disease in a Hungarian cohort

T. Molnár, M. Papp, L. Nagy, 2012, Inflammatory bowel diseases.

[Gene therapy in liver diseases].

Z. Nagy, P. Lakatos, A. Pár, 2002, Orvosi hetilap.

Next-generation sequencing of common osteogenesis imperfecta-related genes in clinical practice

P. Horváth, P. Lakatos, B. Balla, 2016, Scientific Reports.

Polymorphisms of CSF1 and TM7SF4 genes in a case of mild juvenile Paget’s disease found using next-generation sequencing

P. Lakatos, P. Juhasz, B. Balla, 2015, Croatian medical journal.

Randomized clinical trial to comparing efficacy of daily, weekly and monthly administration of vitamin D3

P. Lakatos, I. Takács, L. Szekeres, 2016, Endocrine.

Vitamin D receptor, oestrogen receptor-alpha and calcium-sensing receptor genotypes, bone mineral density and biochemical markers in Paget's disease of bone.

P. Lakatos, P. Gergely, Á. Tabák, 2004, Rheumatology.

The incidence of glomerulonephritis in a population-based inception cohort of patients with inflammatory bowel disease.

P. Lakatos, E. Mácsai, L. Lakatos, 2017, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Phenotypic polymorphism of haptoglobin: a novel risk factor for the development of infection in liver cirrhosis.

G. Veres, M. Papp, P. Lakatos, 2011, Human immunology.

Eight years of denosumab treatment in postmenopausal women with osteoporosis: results from the first five years of the freedom extension

J. Reginster, C. Roux, E. Franek, 2014 .

Report on a case of fibrogenesis imperfecta ossium and a possible new treatment option

P. Lakatos, I. Takács, Á. Lukáts, 2014, Osteoporosis International.

Genetic variants of VDR and CYP2R1 affect BMI independently of serum vitamin D concentrations

P. Horváth, P. Lakatos, Á. Tabák, 2020, BMC Medical Genetics.

NKX2-3 and IRGM variants are associated with disease susceptibility to IBD in Eastern European patients.

A. Tordai, T. Molnár, M. Papp, 2010, World journal of gastroenterology.

Serum 25-hydroxy-vitamin D and the risk of fractures in the teriparatide versus risedronate VERO clinical trial

P. Geusens, E. Lespessailles, P. López-Romero, 2019, Archives of Osteoporosis.

Herpes Zoster Incidence in Inflammatory Bowel Disease Patients: A Population-Based Study.

A. Bitton, P. Lakatos, T. Bessissow, 2018, Inflammatory bowel diseases.

Serological studies in inflammatory bowel disease: how important are they?

M. Papp, P. Lakatos, 2014, Current opinion in gastroenterology.

Superior Gains in Bone Mineral Density (BMD) and Estimated Strength at the Hip for Romosozumab Compared With Teriparatide (TPTD) in Women With Postmenopausal Osteoporosis Transitioning From Bisphosphonate Therapy: Results of the Phase 3 Open-label STRUCTURE Study

Jacques P. Brown, H. Genant, T. Keaveny, 2016 .

Treatment preferences of originator versus biosimilar drugs in Crohn’s disease; discrete choice experiment among gastroenterologists

P. Lakatos, M. Péntek, P. Baji, 2016, Scandinavian journal of gastroenterology.

European Experience of Infliximab Biosimilars for the Treatment of Inflammatory Bowel Disease.

P. Lakatos, 2016, Gastroenterology & hepatology.

F. Nagy, M. Papp, P. Lakatos, 2015 .

The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.

P. Lakatos, A. Szendrői, I. Romics, 2010, The Canadian journal of urology.

The effect of 3 versus 6 years of zoledronic acid treatment in osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)

S. Cummings, S. Boonen, J. Cauley, 2011 .

Androgens and bone mineral content in patients with subtotal thyroidectomy for benign nodular disease.

P. Lakatos, G. Tarján, I. Holló, 1989, Acta medica Hungarica.

P518 Vedolizumab trough concentrations are associated with endoscopic response in patients with inflammatory bowel disease

A. Bitton, E. Seidman, C. Chao, 2018 .

[Cardiovascular side effects of non-steroidal anti-inflammatory drugs in the light of recent recommendations. Diclofenac is not more dangerous].

P. Lakatos, G. Szabó, V. Horváth, 2015, Orvosi hetilap.

P252 - Characteristics of patients prospectively recruited in the Hungarian Pediatric IBD Registry (HUPIR)

G. Veres, M. Papp, P. Lakatos, 2009 .

Vitamin D-neutralizing CYP24A1 expression, oncogenic mutation states and histological findings of human papillary thyroid cancer

P. Horváth, J. Podani, P. Lakatos, 2015, Journal of Endocrinological Investigation.

Foreign body impaction in the sigmoid colon: a twenty euro bet.

G. Veres, M. Papp, P. Lakatos, 2013, World Journal of Gastroenterology.

K. Farkas, T. Molnár, M. Papp, 2015 .

Evidence for direct non-genomic effects of triiodothyronine on bone rudiments in rats: stimulation of the inositol phosphate second messenger system.

P. Lakatos, P. Stern, 1991, Acta endocrinologica.

ATG16L1 and IL23 receptor (IL23R) genes are associated with disease susceptibility in Hungarian CD patients.

A. Tordai, T. Molnár, M. Papp, 2008, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

ATG16L1 and IL-23 receptor (IL-23R) genes are associated with disease susceptibility in Hungarian CD patients

T. Molnár, M. Papp, Z. Tulassay, 2008 .

Association of β-defensin 1 single nucleotide polymorphisms with Crohn's disease

P. Lakatos, Y. Mándi, J. Papp, 2008 .

Corrigendum to “Incidence and Paris Classification of Pediatric Inflammatory Bowel Disease”

G. Veres, M. Papp, P. Lakatos, 2015, Gastroenterology research and practice.

Decreased Bone Density, Elevated Serum Osteoprotegerin, and β‐Cross‐Laps in Wilson Disease

P. Lakatos, F. Szalay, D. Hegedűs, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Sa1156 Accelerated Treatment Strategy in Inflammatory Bowel Diseases; Is It Associated With a Change in the Disease Course?

K. Farkas, T. Molnár, M. Papp, 2015 .

Clinical efficacy, drug sustainability and serum drug levels in Crohn's disease patients treated with ustekinumab - A prospective, multicenter cohort from Hungary.

K. Farkas, T. Molnár, P. Sarlós, 2021, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Do You See What I See? An Assessment of Endoscopic Lesions Recognition and Description by Gastroenterology Trainees and Staff Physicians

A. Bitton, P. Lakatos, B. Bressler, 2019, Journal of the Canadian Association of Gastroenterology.

Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.

A. Forbes, M. Papp, P. Lakatos, 2015, Clinica chimica acta; international journal of clinical chemistry.

Adenocarcinoma Within Carpet-Like Pseudopolyposis

P. Lakatos, T. Bessissow, Yasi Xiao, 2020, ACG case reports journal.

Chronic hepatitis C virus infection associated with autonomic dysfunction

J. Féher, P. Lakatos, M. Kollai, 2009, Liver international : official journal of the International Association for the Study of the Liver.

Co-occurrence of thyroid and breast cancer is associated with an increased oncogenic SNP burden

P. Lakatos, M. Dank, A. Kiss, 2021, BMC cancer.

Challenges in calculating the risk for colorectal cancer in patients with ulcerative colitis.

P. Lakatos, L. Lakatos, 2012, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Elevated Serum Tumor Necrosis Factor-α and Endothelin 1 Levels Correlate With Increased C-Peptide Concentration in Android Type Obesity

P. Lakatos, G. Winkler, K. Cseh, 1998, Diabetes Care.

[General anesthesia during double balloon enteroscopy--Hungarian experiences].

P. Lakatos, J. Papp, L. Zubek, 2010, Orvosi hetilap.

Lack of association between the calcium-sensing receptor (CaSR) A986S polymorphism and colorectal cancer

P. Lakatos, J. Papp, Z. Nagy, 2003 .

Prevalence of adenocarcinoma of the oesophagus and gastrooesophageal junction between 1993–2003

P. Lakatos, J. Papp, J. Halász, 2005 .

No change in location of colorectal cancer between 1993–2004 in Hungarian patients

P. Lakatos, J. Papp, A. Bursics, 2005 .

[Incidence and pathologic distribution of esophageal cancers at the gastro-esophageal junction between 1993-2003].

P. Lakatos, J. Papp, P. Lukovich, 2005, Orvosi Hetilap.

[Significance of serum calcium levels in colorectal cancer].

P. Lakatos, Á. Tabák, J. Papp, 2004, Orvosi Hetilap.

[Familial adenomatous polyposis coli--case report].

P. Lakatos, J. Halász, L. Lakatos, 2004, Orvosi hetilap.

Elevated plasma nociceptin level in patients with Wilson disease

P. Lakatos, J. Reiczigel, F. Szalay, 2002, Brain Research Bulletin.

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 Year results from the MOBILE study (Annals of the Rheumatic Diseases (2006) 65, (654-661))

J. Reginster, S. Silverman, P. Lakatos, 2008 .

[Significance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases].

P. Lakatos, Á. Lazáry, B. Balla, 2007, Orvosi Hetilap.

Extraintestinal Manifestations of Inflammatory Bowel Disease

G. Rogler, A. Schoepfer, S. Vavricka, 2015, Inflammatory bowel diseases.

Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples

P. Horváth, P. Lakatos, A. Tőkés, 2014, Familial Cancer.

NOD2/CARD15 SNP8, 12 and 13 and other EXON4 mutations and primary biliary cirrhosis (PBC) in Hungarian and Polish patients

P. Lakatos, P. Ferenci, A. Habior, 2004 .

Incidence rates and disease course of pediatric inflammatory bowel diseases in western Hungary between 1977 – 2011

G. Veres, P. Lakatos, M. Mandel, 2014 .

Diagnostic and clinical significance of Crohn's disease-specific anti-MZGP2 pancreatic antibodies by a novel ELISA.

A. Forbes, M. Papp, P. Lakatos, 2015, Clinica chimica acta; international journal of clinical chemistry.

Esophageal Squamous Cell Carcinoma With Colonic Metastases

P. Lakatos, T. Bessissow, L. Ferri, 2020, ACG case reports journal.

Serum 25(OH)-vitamin D levels and bone metabolism in patients on maintenance hemodialysis.

K. Berta, C. Ambrus, I. Mucsi, 2005, Clinical nephrology.

DOP074 Adalimumab monotherapy versus combination therapy with adalimumab and immunomodulators for Crohn's disease: A meta-analysis

A. Bitton, E. Seidman, U. Kopylov, 2014 .

[Change in location of colorectal cancer in Hungarian patients between 1993-2004].

E. Hitre, P. Lakatos, J. Papp, 2006, Orvosi hetilap.

Fast and Robust Next-Generation Sequencing Technique Using Ion Torrent Personal Genome Machine for the Screening of Neurofibromatosis Type 1 (NF1) Gene

P. Horváth, P. Lakatos, M. Dank, 2014, Journal of Molecular Neuroscience.

Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial

P. Geusens, E. Lespessailles, P. López-Romero, 2017, The Lancet.

Allelic variations of RANKL/OPG signaling system are related to bone mineral density and in vivo gene expression.

P. Lakatos, Á. Lazáry, B. Balla, 2010, European Journal of Endocrinology.

The Candidate Oncogene CYP24A1: A Potential Biomarker for Colorectal Tumorigenesis

P. Hershberger, E. Kallay, P. Lakatos, 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

The role of vitamin D, estrogen, calcium sensing receptor genotypes and serum calcium in the pathogenesis of prostate cancer.

P. Lakatos, A. Szendrői, I. Romics, 2011, The Canadian journal of urology.

Geographical variability and environmental risk factors in inflammatory bowel disease

C. O'Morain, M. Vatn, C. Bernstein, 2013, Gut.

Reversible autonomic dysfunction during antiviral treatment in patients with chronic hepatitis C virus infection

J. Féher, H. Blum, P. Lakatos, 2011, Hepatitis monthly.

[Haptoglobin polymorphism in patients with inflammatory bowel diseases].

T. Molnár, M. Papp, P. Lakatos, 2006, Orvosi hetilap.

Therapy of Steroid-Resistant Inflammatory Bowel Disease

G. Rogler, A. Schoepfer, S. Vavricka, 2012, Digestion.

High prevalence of IgA class anti-neutrophil cytoplasmic antibodies (ANCA) is associated with increased risk of bacterial infection in patients with cirrhosis.

G. Veres, M. Papp, P. Lakatos, 2013, Journal of hepatology.

Environmental factors in a population-based inception cohort of inflammatory bowel disease patients in Europe--an ECCO-EpiCom study.

N. Pedersen, C. O'Morain, E. Bjornsson, 2014, Journal of Crohn's & colitis.

Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort

L. French, G. Rogler, A. Schoepfer, 2015, Inflammatory bowel diseases.

Quality of care indicators in inflammatory bowel disease in a tertiary referral center with open access and objective assessment policies.

A. Bitton, P. Lakatos, W. Afif, 2018, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Cost-utility of biological treatment sequences for luminal Crohn’s disease in Europe

L. Peyrin-Biroulet, P. Lakatos, J. Halfvarson, 2017, Expert review of pharmacoeconomics & outcomes research.

Rapid and cost effective screening of breast and ovarian cancer genes using novel sequence capture method in clinical samples

P. Horváth, P. Lakatos, A. Tőkés, 2014, Familial Cancer.

Myocardial infarction is associated with Sp1 binding site polymorphism of collagen type 1A1 gene

Péter Lakatos, P. Lakatos, Á. Tabák, 2006, Acta cardiologica.

New considerations on the management of osteoporosis in Central and Eastern Europe (CEE): summary of the “3rd Summit on Osteoporosis—CEE”, November 2009, Budapest, Hungary

D. Hans, P. Lakatos, B. Obermayer-Pietsch, 2011, Archives of osteoporosis.

Review article: the natural history of paediatric‐onset ulcerative colitis in population‐based studies

V. Annese, L. Peyrin-Biroulet, P. Lakatos, 2016, Alimentary pharmacology & therapeutics.

Discontinuation of Infliximab in Patients With Ulcerative Colitis Is Associated With Increased Risk of Relapse: A Multinational Retrospective Cohort Study.

S. Bonovas, U. Kopylov, S. Sebastian, 2016, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Efficacy and Safety of the Biosimilar Infliximab CT-P13 Treatment in Inflammatory Bowel Diseases: A Prospective, Multicentre, Nationwide Cohort.

K. Farkas, F. Nagy, T. Molnár, 2016, Journal of Crohn's & colitis.

Falk Symposium Series

Claudio Fiocchi, Peter L. Lakatos, Ashwin N. Ananthakrishnan, 2009, Digestive Diseases.

A Retrospective Longitudinal Database Study of Persistence and Compliance with Treatment of Osteoporosis in Hungary

M. Intorcia, P. Lakatos, I. Takács, 2015, Calcified Tissue International.

Prevalence, significance and predictive value of antiphospholipid antibodies in Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, World journal of gastroenterology.

Seasonal variability of vitamin D and bone metabolism in infliximab-treated paediatric Crohn's disease.

G. Veres, M. Papp, P. Lakatos, 2015, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Detection of antineutrophil cytoplasmic antibodies in patients with inflammatory bowel diseases

M. Papp, P. Lakatos, Z. Shums, 2007 .

AB0314 Awareness and Acceptance of Biosimilars by Rheumatologists in Eleven Eu Countries

P. Lakatos, H. Kellner, P. Audhya, 2016 .

Current Concepts on the Genetics and Pharmacogenetics of Inflammatory Bowel Disease: Do they Help in Clinical Management?

P. Lakatos, L. Lakatos, 2006 .

Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977-2001.

P. Lakatos, L. Lakatos, Z. Erdélyi, 2004, World journal of gastroenterology.

[Current concepts in the genetics of hereditary and sporadic colorectal cancer and the role of genetics in clinical practice: sporadic and IBD-associated colorectal tumors, significance of genetic tests in diagnosis, prognosis and assessment of chemotherapy outcome].

P. Lakatos, L. Lakatos, 2006, Orvosi hetilap.

Serum 25(OH)-Cholecalciferol Concentration Is Associated with Hemoglobin Level and Erythropoietin Resistance in Patients on Maintenance Hemodialysis

K. Berta, C. Ambrus, I. Mucsi, 2010, Nephron Clinical Practice.